Literature DB >> 9721332

The role of nitric oxide chemistry in cancer treatment.

D A Wink1, Y Vodovotz, J A Cook, M C Krishna, S Kim, D Coffin, W DeGraff, A M Deluca, J Liebmann, J B Mitchell.   

Abstract

Over the last decade the role of nitric oxide (NO) in various disease states has become apparent. In cancer, NO plays a variety of roles which are at times contradictory. On one hand, NO is involved in different etiological mechanisms as well as promoting tumor growth. Yet, NO derived from leukocytes plays a seminal role in their tumoricidal activity. In cancer treatment, NO also has diverse effects. Whereas in vitro, NO can enhance the cytotoxic efficacy of some chemotherapeutic agents as well as radiation, NO donors can provide whole body protection against these same agents. This manuscript will discuss some mechanisms involved with NO and cancer treatment modalities and the potential application of these findings to cancer therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9721332

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  13 in total

1.  The role of oxidative stress in the development of cisplatin resistance in epithelial ovarian cancer.

Authors:  Jimmy Belotte; Nicole M Fletcher; Awoniyi O Awonuga; Mitchell Alexis; Husam M Abu-Soud; Mohammed G Saed; Michael P Diamond; Ghassan M Saed
Journal:  Reprod Sci       Date:  2013-09-27       Impact factor: 3.060

2.  Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIP.

Authors:  Stavroula Baritaki; Sara Huerta-Yepez; Anna Sahakyan; Iordanis Karagiannides; Kyriaki Bakirtzi; Ali Jazirehi; Benjamin Bonavida
Journal:  Cell Cycle       Date:  2010-12-15       Impact factor: 4.534

3.  Expression of nitric oxide synthase in human gastric carcinoma and its relation to p53, PCNA.

Authors:  Yong-Zhong Wang; You-Qing Cao; Jian-Nong Wu; Miao Chen; Xiao-Ying Cha
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

4.  Effect of nitric oxide on the anticancer activity of the topoisomerase-active drugs etoposide and adriamycin in human melanoma cells.

Authors:  Birandra K Sinha; Ashutosh Kumar; Suchandra Bhattacharjee; Michael G Espey; Ronald P Mason
Journal:  J Pharmacol Exp Ther       Date:  2013-09-18       Impact factor: 4.030

5.  Inhibition of Epithelial-to-Mesenchymal Transition (EMT) in Cancer by Nitric Oxide: Pivotal Roles of Nitrosylation of NF-κB, YY1 and Snail.

Authors:  Benjamin Bonavida; Stavroula Baritaki
Journal:  For Immunopathol Dis Therap       Date:  2012

6.  Sepiapterin ameliorates chemically induced murine colitis and azoxymethane-induced colon cancer.

Authors:  Robert J G Cardnell; Christopher S Rabender; Gracious R Ross; Chunqing Guo; Eric L Howlett; Asim Alam; Xiang-Yang Wang; Hamid I Akbarali; Ross B Mikkelsen
Journal:  J Pharmacol Exp Ther       Date:  2013-08-02       Impact factor: 4.030

7.  Role of nitric oxide in the chemistry and anticancer activity of etoposide (VP-16,213).

Authors:  Birandra K Sinha; Suchandra Bhattacharjee; Saurabh Chatterjee; JinJie Jiang; Ann G Motten; Ashutosh Kumar; Michael Graham Espey; Ronald P Mason
Journal:  Chem Res Toxicol       Date:  2013-02-26       Impact factor: 3.739

8.  Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance.

Authors:  E L Leung; M Fraser; R R Fiscus; B K Tsang
Journal:  Br J Cancer       Date:  2008-05-27       Impact factor: 7.640

Review 9.  The dual role of iNOS in cancer.

Authors:  Federica Vannini; Khosrow Kashfi; Niharika Nath
Journal:  Redox Biol       Date:  2015-08-24       Impact factor: 11.799

10.  iNOS promotes CD24+CD133+ liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway.

Authors:  Ronghua Wang; Yawen Li; Allan Tsung; Hai Huang; Qiang Du; Muqing Yang; Meihong Deng; Si Xiong; Xiju Wang; Liyong Zhang; David A Geller; Bin Cheng; Timothy R Billiar
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.